The 54 references in paper I. Baranova A., S. Krasovsky A., E. Amelina L., И. Баранова А., С. Красовский А., Е. Амелина Л. (2014) “Остеопороз у больных муковисцидозом: новая проблема и нерешенные вопросы // Osteoporosis in cystic fibrosis patients: a new problem and unresolved issues” / spz:neicon:pulmonology:y:2011:i:4:p:126-132

1
Капранов Н.И., Каширская Н.Ю.(ред.). Муковисцидоз. Современные достижения и актуальные проблемы: Метод. рекомендации. 3-е изд. М.: ООО "4ТЕ Арт";
(check this in PDF content)
2
08. 2.Кусова З.А., Каширская Н.Ю., Капранов Н.И.Особенности массового скрининга новорожденных на муковисцидоз. Рус. мед. журн. 2010; 5: 265–270.
(check this in PDF content)
3
Cystic Fibrosis Foundation, patient registry 2008. Annual report Cystic Fibrosis Foundation. Bethesda, Md, USA, 2009.
(check this in PDF content)
4
King S.J., Topliss D.J., Kotsimbos T. et al.Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor. Eur. Respir. J. 2005; 25: 54–61.
(check this in PDF content)
5
Grey A.B., Ames R.W., Matthews R.D. et al. Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 1993; 48: 589–593.
(check this in PDF content)
6
Elkin S.L., Fairney A., Burnett S. et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 2001; 12: 366–372.
(check this in PDF content)
7
Stephenson A., Jamal S., Dowdell T. et al. Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density. Chest 2006; 130: 539–544.
(check this in PDF content)
8
Aris R.M., Renner J.B., Winders A.D. et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann. Intern. Med. 1998; 128 (3): 186–193.
(check this in PDF content)
9
Paccou J., Zeboulon N., Combescure C. et al. The prevalence of osteoporosis, osteopenia, and fractures: a systematic literature review with meta-analysis. Calcif. Tissue Int. 2010; 86: 1–7.
(check this in PDF content)
10
Aringer M., Kiener H.P., Koeller M.D. et al. High turnover bone disease following lung transplantation. Bone 1998; 23 (5): 485–488.
(check this in PDF content)
11
Shane E., Papadopoulos A., Staron R.B. et al. Bone loss and fracture after lung transplantation. Transplantation 1999; 68 (2): 220–227.
(check this in PDF content)
12
Official position of the International Society for Clinical Densitometry. © Copyright ISCD, October 2007, Supersedes all prior "Official Position" publications.
(check this in PDF content)
13
Report of the UK Cystic Fibrosis Trust Bone Mineralisation Working Group. Bone mineralisation in cystic fibrosis. February 2007. Cystic Fibrosis Trust.
(check this in PDF content)
14
Aris R.M., Merkel P.A., Bachrach L.K. et al.Consensus statement: Guide to bone health and disease in cystic fibrosis. J. Clin. Endocrinol. 2005; 90 (3):1888–1896.
(check this in PDF content)
15
Haworth C.S., Webb A.K., Egan J.J. et al. Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000; 118: 434–439.
(check this in PDF content)
16
Elkin S.L., Vedi S., Bord S. et al.Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2002; 166: 1470–1474.
(check this in PDF content)
17
Mischler E.H., Chesney P.J., Chesney R.W. et al. Demineralization in cystic fibrosis detected by direct photon absorptiometry. Am. J. Dis. Child. 1979; 133: 632–635.
(check this in PDF content)
18
Hahn T.J., Squires A.E., Halstead L.R. et al.Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. J. Pediatr.
(check this in PDF content)
19
9; 94: 38–42. 19.Paccou J., Zeboulon N., Combescure C. et al.The prevalence of osteoporosis, osteopenia, and fractures: a systematic literature review with meta-analysis. Calcif. Tissue Int. 2010; 86: 1–7.
(check this in PDF content)
20
Haworth C.S., Selby P.L., Webb A.K. et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999; 54: 961–967.
(check this in PDF content)
21
Buntain H.M., Schluter P.J., Bell S.C. et al. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax 2006; 61: 146–154.
(check this in PDF content)
22
Haworth C.S., Selby P.L., Horrrocks A.W. et al. A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax 2002; 57: 719–723.
(check this in PDF content)
23
Bhudhikanok G.S., Wang M.)C., Marcus R. et al. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J. Pediatr. 1998; 133: 18–27.
(check this in PDF content)
24
Dif F., Marty C., Baudoin C. et al.Severe osteopenia in CFTR-null mice. Bone 2004; 35: 595–603.
(check this in PDF content)
25
Haston C.K., Li W., Li A. et al.Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice. Am. J. Respir. Crit. Care Med. 2008; 177: 309–315.
(check this in PDF content)
26
King S.L., Topliss D.J., Kotsimbos T. et al. Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor. Eur. Respir. J. 2005; 25: 54–61.
(check this in PDF content)
27
Buntain H.M., Greer R.M., Schluter P.J. et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004; 59: 149–155.
(check this in PDF content)
28
Aris R.M., Guise T.A.Cystic fibrosis and bone disease: are we missing a genetic link? Eur. Respir. J. 2005; 25 (1): 9–11.
(check this in PDF content)
29
Shead E.F., Haworth C.S., Condliffe A.M. et al. Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax 2007; 62: 650–651.
(check this in PDF content)
30
Le Heron L., Guillaume C., Velard F. et al.Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. J. Cyst. Fibros. 2010; 9: 69–72.
(check this in PDF content)
31
Lacativa P.G.S., de Farias V.L.F. Osteoporosis and inflammation. Arq. Bras. Endocrinol. 2010: 54 (2): 123–132.
(check this in PDF content)
32
Shead E.F., Haworth C.S., Gunn E. et al. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2006; 174: 306–311.
(check this in PDF content)
33
Shead E.F., Haworth C.S., Barker H. et al. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J. Cyst. Fibros. 2010; 9: 93–98.
(check this in PDF content)
34
Ionescu A., Nixon L., Evans W. et al.Bone density, body composition, and inflammatory status in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2000; 162 (3): 789–794.
(check this in PDF content)
35
Aris R., Stephens A., Ontjes D. et al. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2000; 162 (5): 1674–1678.
(check this in PDF content)
36
Haworth C., Selby P., Webb A. et al.Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax 2004; 59 (7): 613–617.
(check this in PDF content)
37
Boyle M.P., Noschese M.L., Watts S.L. et al. Failure of highdose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2005; 172 (2): 212–217.
(check this in PDF content)
38
Rovner A.J., Stallings V.A., Schall J.A. et al. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am. J. Clin. Nutr. 2007; 86 (6): 1694-1699.
(check this in PDF content)
39
Hall W.B., Sparks A.A., Aris R.M. Vitamin D deficiency in cystic fibrosis. Int. J. Endocrinol. 2010: Article ID 218691.
(check this in PDF content)
40
Cranney A., Horsley T., O'Donnell S. et al. Effectiveness and safety of vitamin D in relation to bone health. Evidence Report / Technology Assessment 2007; 158: 1–235.
(check this in PDF content)
41
Wolfenden L.L., Judd S.E., Shah R. et al. Vitamin D and bone health in adults with cystic fibrosis. Clin. Endocrinol. 2008; 69: 374–381.
(check this in PDF content)
42
Gronowitz E., LarköO., Gilljam M. et al.Ultraviolet B radiation improves serum levels of vitamin D in patients with cystic fibrosis. Acta Paediatr. 2005; 94 (5): 547–552. Баранова И.А. и др.Остеопороз у больных муковисцидозом: новая проблема и нерешенные вопросы
(check this in PDF content)
43
Khazai N.B., Judd S.E., Jeng L. et al. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J. Clin. Endocrinol. 2009; 94: 2037–2043.
(check this in PDF content)
44
Conway S.P., Wolfe S.P., Brownlee K.G. et al.Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 2005; 115: 1325–1331.
(check this in PDF content)
45
Fewtrell M.S., Benden C., Williams J.E. et al. Undercarboxylated osteocalcin and bone mass in 8–12 year old children with cystic fibrosis. J. Cyst. Fibros. 2008; 7: 307–312.
(check this in PDF content)
46
Grey V., Atkinson S., Drury D. et al.Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008; 122: 1014–1020.
(check this in PDF content)
47
Nicolaidou P., Stavrinadis I., Loukou I. et al. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur. J. Pediatr. 2006; 165: 540–545.
(check this in PDF content)
48
Drury D., Grey V.L., Ferland G. et al.Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. J. Cyst. Fibros. 2008; 7: 457–459.
(check this in PDF content)
49
Aris R.M., Lester G.E., Renner J.B. et al.Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am. J. Respir. Crit. Care Med. 2000; 162 (3, Pt 1): 941–946.
(check this in PDF content)
50
Aris R.M., Lester G.E., Caminiti M. et al. Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am. J. Res. Crit. Care Med. 2004; 169 (1): 77–82.
(check this in PDF content)
51
Boyle M.P., Lechtzin N., Watts S. Zoledronate therapy for decreased bone density in adults with cystic fibrosis [abstract]. Pediatr. Pulmonol. 2005; 40 (S28): 353.
(check this in PDF content)
52
Chapman I., Greville H., Ebeling P.R. et al. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF). Clin. Endocrinol. 2009; 70: 838–846.
(check this in PDF content)
53
Haworth C.S., Selby P.L., Adams J.E. et al. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 2001; 56 (4): 314–316.
(check this in PDF content)
54
Papaioannou A., Kennedy C.C., Freitag A. et al.Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS Trial). Chest 2008; 134: 794–800. Информация об авторах
(check this in PDF content)